| Value | ₹15.57 Cr |
|---|
BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Drugs and Organics Ltd: key numbers
- Share price
- ₹29.10
- Market cap
- ₹46.06 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.2×Sector 46.1×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Drugs and Organics Ltd
All →Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.
Mangalam Drugs and Organics Debt & Borrowing: ₹1,557 Cr
Mangalam Drugs and Organics Limited has reported a default amounting to Rs.1,557.27 Crore. The company has submitted a restructuring proposal to its banks to manage the obligation.
- Value
- ₹1,557 Cr
Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr
Mangalam Drugs and Organics Limited reported defaults on bank loan obligations totaling Rs. 15.57 Crore. The defaults involve cash credit accounts at Bank of Maharashtra and Bank of Baroda.
- Value
- ₹15.57 Cr
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs and Organics Limited has issued a Postal Ballot notice to seek shareholder approval for appointing Shri Prabhakar Raghunath Zavar as an Independent Director. The appointment is for five years.
Mangalam Drugs and Organics Other Announcement
Mangalam Drugs and Organics Limited announced the appointment of new Statutory and Secretarial Auditors following the tenure completion of the previous Statutory Auditor.
Other debt & borrowing announcements
All →Ugro Capital Debt & Borrowing: ₹2.99 Cr
Ugro Capital paid Rs 2.99 Crore in interest on two NCD series on 29 October 2026. Payments were made a day before the 30 October due date.
- Value
- ₹2.99 Cr
Time Technoplast Debt & Borrowing: ₹50 Cr
Time Technoplast redeemed its Rs.50 Crore commercial paper in full on maturity on 29 October 2026. The redemption completes servicing of this short-term debt instrument.
- Value
- ₹50.00 Cr
Samvardhana Motherson International Debt & Borrowing: ₹834.8 Cr
Samvardhana Motherson issued a corporate guarantee for a EUR 75 million BNP Paribas term facility of subsidiary MGI B.V. Liability capped at ₹834.75 Crore.
- Value
- ₹834.8 Cr
- Execution
- Guarantee valid up to February 28, 2032
Electrotherm (India) Debt & Borrowing: ₹59.81 Cr
Electrotherm disclosed a Rs 59.81 Crore default on bank loans as at 30 September 2026. The loans were assigned to an ARC under a settlement.
- Value
- ₹59.81 Cr
Shree Renuka Sugars Debt & Borrowing: ₹1.55 Cr
Shree Renuka Sugars paid monthly interest on four listed NCD series on October 29, 2026. Total interest paid across the series is Rs. 1.58 Crore.
- Value
- ₹1.55 Cr
Avenue Supermarts Debt & Borrowing: ₹200 Cr
Avenue Supermarts allotted Rs 200 crore of unsecured commercial paper on 29 October 2026, maturing 11 December 2026 at 7.20% coupon. The paper carries an ICRA A1+ rating and is proposed to be listed on BSE.
- Value
- ₹200.0 Cr
- Execution
- 43 days